Guan Q, Liao X, He M, Li X, Wang Z, Ma H, Yu S, Liu S
Exendin-4 has the effect of lowering blood pressure and inducing aortic vasodilation [3]
Several variables may influence whether stomach function returns after stopping GLP-1 medications: Duration and dosage: Longer exposure and higher doses may increase permanent damage likelihood Pre-existing vulnerabilities: Patients with borderline slow emptying, prior surgery, diabetes, or autoimmune conditions may experience irreversible damage Individual metabolic factors: Variations in semaglutide metabolism may explain different outcomes Timing of intervention: Immediate discontinuation upon symptoms may improve recovery prospects The pharmaceutical industrys failure to conduct long-term outcome studies has left patients and the medical community without guidance
Current guidelines do not recommend this supplement for preventing CIPN (54)
Individuals focused on athletic performance or fat metabolism may benefit from slightly higher amounts under proper guidance